Clinical comparison and functional study of the L703P: a recurrent mutation in human SCN4A that causes sodium channel myotonia
Qing Ke, Youcheng Zhao, Yuezhou Li, Jia Ye, Siyang Tang, Fangping He, Fang Ji, Xuejiao Dai, Jie Ni, Yi Li, Robert C. Griggs, Xiaoyang Cheng
Journal:NEUROMUSCULAR DISORDERS
IF:3.54
DOI:10.1016/j.nmd.2022.08.004
PMID:36050252
Published:2022-08-17
research field:高分子科学心血管器械生物医学工程材料科学组织工程
Abstract
The non-dystrophic myotonias are inherited skeletal muscle disorders characterized by skeletal muscle stiffness after voluntary contraction, without muscle atrophy. Based on their clinical features, non-dystrophic myotonias are classified into myotonia congenita, paramyotonia congenita, and sodium channel myotonia. Using whole-exome next-generation sequencing, we identified a L703P mutation (c.2108T>C, p.L703P) in SCN4A in a Chinese family diagnosed with non-dystrophic myotonias. The clinical findings of patients in this family included muscle stiffness and hypertrophy. The biophysical properties of wildtype and mutant channels were investigated using whole-cell patch clamp. L703P causes both gain-of-function and loss-of-function changes in Nav1.4 properties, including decreased current density, impaired recovery, enhanced activation and slow inactivation. Our study demonstrates that L703P is a pathogenic variant for myotonia, and provides additional electrophysiological information for understanding the pathogenic mechanism of SCN4A -associated channelopathies.
本文使用的Yeasen产品


